Consainsights logo
Reports / Oral Thin Film Drugs Market

Oral Thin Film Drugs Market

Oral Thin Film Drugs Market Research Report – Segmented By Product (ORAL THIN FILM, OTHERS, TRANSDERMAL THIN FILM), Disease Indication (MIGRAINE, NAUSEA & VOMITING, OPIOID DEPENDENCE, OTHERS, SCHIZOPHRENIA) & Region (North America, Europe, APAC, Latin America, Middle East and Africa) – Analysis on Size, Share, Trends, COVID-19 Impact, Competitive Analysis, Growth Opportunities and Key Insights from 2017 to 2026.


01

Executive Summary

Oral Thin Film Drugs Market was valued at US $9.05 billion in 2021 and is projected to grow at 10.91% CAGR over the forecast period to reach US $16.84 billion by 2027. Oral Thin Film Drugs Market represented US $1.69 billion opportunity over 2019-2021 and estimated to create US $7.79 billion opportunity in 2027 over 2021.

Oral Thin Film Drugs from Consainsights analyses the Oral Thin Film Drugs Market in the Life Sciences industry over the forecast period to 2027.

Oral Thin Film Drugs research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Oral Thin Film Drugs segmentation includes Product, Disease Indication and Geography.

Based on the Product, the Oral Thin Film Drugs analysis covers ORAL THIN FILM, TRANSDERMAL THIN FILM, OTHERS.

In Product segment, ORAL THIN FILM segment has highest cagr growth of 9.64%.

Based on the Disease Indication, the Oral Thin Film Drugs analysis covers SCHIZOPHRENIA, MIGRAINE, OPIOID DEPENDENCE, NAUSEA & VOMITING, OTHERS.

In Disease Indication segment, SCHIZOPHRENIA segment has highest cagr growth of 9.64%.

Based on the region, the Oral Thin Film Drugs analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include MONOSOL RX, TESA LABTEC GMBH, PFIZER, INC, NOVARTIS AG, WOLTERS KLUWER, SOLVAY, ALLERGAN PLC, SUMITOMO DAINIPPON PHARMA CO. LTD, INTELGENX CORP, TRANSITION THERAPEUTICS, INC. and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

  • Revenue Share (%), By Product (2021)
    Revenue Share (%), By Product (2021)
  • Revenue Share (%), By Disease Indication (2021)
    Revenue Share (%), By Disease Indication (2021)
02

Market Overview

  • The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.
  • The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.
  • The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.
  • Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.
  • Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.
  • As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.
  • The currency used in this report is USD, with the market size indicated in terms of USD million/billion.
  • For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.
  • For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.
03

By Product

  • ORAL THIN FILM accounted for US$3.43 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • TRANSDERMAL THIN FILM accounted for US$2.61 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • OTHERS accounted for US$3.01 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Oral Thin Film Drugs Market Y-o-Y Growth (USD billion), By Product 2019 - 2027
Oral Thin Film Drugs Market Y-o-Y Growth (USD billion), By Product 2019 - 2027
Oral Thin Film Drugs Market Size, By Product, 2019-2027 (USD billion)
Oral Thin Film Drugs Market Size, By Product, 2019-2027 (USD billion)

The ORAL THIN FILM segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

ORAL THIN FILM: global Oral Thin Film Drugs Market Revenue Opportunity (Us$ Mn)
ORAL THIN FILM: global Oral Thin Film Drugs Market Revenue Opportunity (Us$ Mn)

The OTHERS segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

OTHERS: global Oral Thin Film Drugs Market Revenue Opportunity (Us$ Mn)
OTHERS: global Oral Thin Film Drugs Market Revenue Opportunity (Us$ Mn)

The TRANSDERMAL THIN FILM segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

TRANSDERMAL THIN FILM: global Oral Thin Film Drugs Market Revenue Opportunity (Us$ Mn)
TRANSDERMAL THIN FILM: global Oral Thin Film Drugs Market Revenue Opportunity (Us$ Mn)
04

By Disease Indication

  • SCHIZOPHRENIA accounted for US$3.55 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • MIGRAINE accounted for US$2.04 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • OPIOID DEPENDENCE accounted for US$1.89 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • NAUSEA & VOMITING accounted for US$1.24 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • OTHERS accounted for US$0.33 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Oral Thin Film Drugs Market Y-o-Y Growth (USD billion), By Disease Indication 2019 - 2027
Oral Thin Film Drugs Market Y-o-Y Growth (USD billion), By Disease Indication 2019 - 2027
Oral Thin Film Drugs Market Size, By Disease Indication, 2019-2027 (USD billion)
Oral Thin Film Drugs Market Size, By Disease Indication, 2019-2027 (USD billion)

The MIGRAINE segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

MIGRAINE: global Oral Thin Film Drugs Market Revenue Opportunity (Us$ Mn)
MIGRAINE: global Oral Thin Film Drugs Market Revenue Opportunity (Us$ Mn)

The NAUSEA & VOMITING segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

NAUSEA & VOMITING: global Oral Thin Film Drugs Market Revenue Opportunity (Us$ Mn)
NAUSEA & VOMITING: global Oral Thin Film Drugs Market Revenue Opportunity (Us$ Mn)

The OPIOID DEPENDENCE segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

OPIOID DEPENDENCE: global Oral Thin Film Drugs Market Revenue Opportunity (Us$ Mn)
OPIOID DEPENDENCE: global Oral Thin Film Drugs Market Revenue Opportunity (Us$ Mn)

The OTHERS segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

OTHERS: global Oral Thin Film Drugs Market Revenue Opportunity (Us$ Mn)
OTHERS: global Oral Thin Film Drugs Market Revenue Opportunity (Us$ Mn)

The SCHIZOPHRENIA segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

SCHIZOPHRENIA: global Oral Thin Film Drugs Market Revenue Opportunity (Us$ Mn)
SCHIZOPHRENIA: global Oral Thin Film Drugs Market Revenue Opportunity (Us$ Mn)
05

North America

  • In 2021, North America segment accounted for US$9.05 Bn and is expected grow with a CAGR of 10.91% over the forecast years.
  • In North America, United States accounted for US$6.25 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Canada accounted for US$2.80 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
North America Oral Thin Film Drugs Market, By Country, 2019-2027 (USD billion)
North America Oral Thin Film Drugs Market, By Country, 2019-2027 (USD billion)
North America Oral Thin Film Drugs Market - Market Opportunity (USD billion), 2019, 2021 & 2027
North America Oral Thin Film Drugs Market - Market Opportunity (USD billion), 2019, 2021 & 2027
Revenue Share (%), By Product - North America (2021)
Revenue Share (%), By Product - North America (2021)
Revenue Share (%), By Disease Indication - North America (2021)
Revenue Share (%), By Disease Indication - North America (2021)
North America Oral Thin Film Drugs Market, By Country, 2019-2027 (USD billion)
North America Oral Thin Film Drugs Market, By Country, 2019-2027 (USD billion)
United States Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027
United States Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027
United States Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Disease Indication, 2019-2027
United States Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Disease Indication, 2019-2027
Canada Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027
Canada Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027
Canada Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Disease Indication, 2019-2027
Canada Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Disease Indication, 2019-2027
06

Europe

  • In 2021, Europe segment accounted for US$9.05 Bn and is expected grow with a CAGR of 10.91% over the forecast years.
  • In Europe, Germany accounted for US$3.64 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • United Kingdom accounted for US$2.31 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • France accounted for US$1.46 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Spain accounted for US$0.79 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Russia accounted for US$0.57 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Italy accounted for US$0.25 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Rest of Europe accounted for US$0.04 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Europe Oral Thin Film Drugs Market, By Country, 2019-2027 (USD billion)
Europe Oral Thin Film Drugs Market, By Country, 2019-2027 (USD billion)
Europe Oral Thin Film Drugs Market - Market Opportunity (USD billion), 2019, 2021 & 2027
Europe Oral Thin Film Drugs Market - Market Opportunity (USD billion), 2019, 2021 & 2027
Revenue Share (%), By Product - Europe (2021)
Revenue Share (%), By Product - Europe (2021)
Revenue Share (%), By Disease Indication - Europe (2021)
Revenue Share (%), By Disease Indication - Europe (2021)
Europe Oral Thin Film Drugs Market, By Country, 2019-2027 (USD billion)
Europe Oral Thin Film Drugs Market, By Country, 2019-2027 (USD billion)
Germany Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027
Germany Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027
Germany Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Disease Indication, 2019-2027
Germany Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Disease Indication, 2019-2027
United Kingdom Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027
United Kingdom Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027
United Kingdom Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Disease Indication, 2019-2027
United Kingdom Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Disease Indication, 2019-2027
France Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027
France Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027
France Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Disease Indication, 2019-2027
France Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Disease Indication, 2019-2027
Spain Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027
Spain Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027
Spain Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Disease Indication, 2019-2027
Spain Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Disease Indication, 2019-2027
Russia Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027
Russia Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027
Russia Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Disease Indication, 2019-2027
Russia Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Disease Indication, 2019-2027
Italy Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027
Italy Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027
Italy Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Disease Indication, 2019-2027
Italy Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Disease Indication, 2019-2027
Rest of Europe Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027
Rest of Europe Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027
Rest of Europe Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Disease Indication, 2019-2027
Rest of Europe Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Disease Indication, 2019-2027
07

Asia-Pacific

  • In 2021, Asia-Pacific segment accounted for US$9.05 Bn and is expected grow with a CAGR of 10.91% over the forecast years.
  • In Asia-Pacific, China accounted for US$3.76 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Japan accounted for US$2.55 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • India accounted for US$1.23 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Southeast Asia accounted for US$0.68 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Australia & New Zealand accounted for US$0.66 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Rest of Asia-Pacific accounted for US$0.17 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Asia-Pacific Oral Thin Film Drugs Market, By Country, 2019-2027 (USD billion)
Asia-Pacific Oral Thin Film Drugs Market, By Country, 2019-2027 (USD billion)
Asia-Pacific Oral Thin Film Drugs Market - Market Opportunity (USD billion), 2019, 2021 & 2027
Asia-Pacific Oral Thin Film Drugs Market - Market Opportunity (USD billion), 2019, 2021 & 2027
Revenue Share (%), By Product - Asia-Pacific (2021)
Revenue Share (%), By Product - Asia-Pacific (2021)
Revenue Share (%), By Disease Indication - Asia-Pacific (2021)
Revenue Share (%), By Disease Indication - Asia-Pacific (2021)
Asia-Pacific Oral Thin Film Drugs Market, By Country, 2019-2027 (USD billion)
Asia-Pacific Oral Thin Film Drugs Market, By Country, 2019-2027 (USD billion)
China Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027
China Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027
China Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Disease Indication, 2019-2027
China Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Disease Indication, 2019-2027
Japan Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027
Japan Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027
Japan Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Disease Indication, 2019-2027
Japan Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Disease Indication, 2019-2027
India Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027
India Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027
India Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Disease Indication, 2019-2027
India Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Disease Indication, 2019-2027
Southeast Asia Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027
Southeast Asia Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027
Southeast Asia Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Disease Indication, 2019-2027
Southeast Asia Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Disease Indication, 2019-2027
Australia & New Zealand Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027
Australia & New Zealand Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027
Australia & New Zealand Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Disease Indication, 2019-2027
Australia & New Zealand Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Disease Indication, 2019-2027
Rest of Asia-Pacific Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027
Rest of Asia-Pacific Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027
Rest of Asia-Pacific Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Disease Indication, 2019-2027
Rest of Asia-Pacific Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Disease Indication, 2019-2027
08

Middle East & Africa

Based on the Middle East & Africa, the Oral Thin Film Drugs Market analysis covers Middle East, Africa, Rest of Middle East & Africa.

Middle East & Africa Map
Middle East & Africa Oral Thin Film Drugs Market Size, 2019-2027 (Us$ Mn)
Middle East & Africa Oral Thin Film Drugs Size, 2019-2027 (Us$ Mn)
Middle East & Africa Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027
Middle East & Africa Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027
Middle East & Africa Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Disease Indication, 2019-2027
Middle East & Africa Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Disease Indication, 2019-2027
Middle East Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027
Middle East Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027
Middle East Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Disease Indication, 2019-2027
Middle East Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Disease Indication, 2019-2027
Africa Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027
Africa Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027
Africa Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Disease Indication, 2019-2027
Africa Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Disease Indication, 2019-2027
Rest of Middle East & Africa Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027
Rest of Middle East & Africa Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027
Rest of Middle East & Africa Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Disease Indication, 2019-2027
Rest of Middle East & Africa Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Disease Indication, 2019-2027
09

Latin America

  • In 2021, Latin America segment accounted for US$9.05 Bn and is expected grow with a CAGR of 10.91% over the forecast years.
  • In Latin America, Brazil accounted for US$4.12 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Argentina accounted for US$2.01 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Mexico accounted for US$1.66 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Colombia accounted for US$1.08 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Rest of Latin America accounted for US$0.18 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Latin America Oral Thin Film Drugs Market, By Country, 2019-2027 (USD billion)
Latin America Oral Thin Film Drugs Market, By Country, 2019-2027 (USD billion)
Latin America Oral Thin Film Drugs Market - Market Opportunity (USD billion), 2019, 2021 & 2027
Latin America Oral Thin Film Drugs Market - Market Opportunity (USD billion), 2019, 2021 & 2027
Revenue Share (%), By Product - Latin America (2021)
Revenue Share (%), By Product - Latin America (2021)
Revenue Share (%), By Disease Indication - Latin America (2021)
Revenue Share (%), By Disease Indication - Latin America (2021)
Latin America Oral Thin Film Drugs Market, By Country, 2019-2027 (USD billion)
Latin America Oral Thin Film Drugs Market, By Country, 2019-2027 (USD billion)
Brazil Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027
Brazil Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027
Brazil Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Disease Indication, 2019-2027
Brazil Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Disease Indication, 2019-2027
Argentina Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027
Argentina Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027
Argentina Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Disease Indication, 2019-2027
Argentina Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Disease Indication, 2019-2027
Mexico Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027
Mexico Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027
Mexico Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Disease Indication, 2019-2027
Mexico Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Disease Indication, 2019-2027
Colombia Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027
Colombia Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027
Colombia Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Disease Indication, 2019-2027
Colombia Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Disease Indication, 2019-2027
Rest of Latin America Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027
Rest of Latin America Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Product, 2019-2027
Rest of Latin America Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Disease Indication, 2019-2027
Rest of Latin America Oral Thin Film Drugs Market - Historical, Forecast Market Sizes (US$ MN), By Disease Indication, 2019-2027
10

Company Analysis

  • MONOSOL RX
  • TESA LABTEC GMBH
  • PFIZER, INC
  • NOVARTIS AG
  • WOLTERS KLUWER
  • SOLVAY
  • ALLERGAN PLC
  • SUMITOMO DAINIPPON PHARMA CO. LTD
  • INTELGENX CORP
  • TRANSITION THERAPEUTICS, INC.